December 10, 2013
Opportunities Emerging from Biotech and ICT
Blogs from the Forum
Microsoft's Mike Nelson felt it was important to broaden the question. He believed we should focus on the emerging technologies for keeping people healthy, before they get sick, so we can keep them healthy in the first place. Novel ICT applications collect biometric data for this purpose, which in turn can -- and are -- shared socially online.
The moderator, Scientific American's Dina Maron, asked what these technologies will do regarding social inequality. The panelists agreed that handheld devices are enormous enabling devices for health -- smart phones, for example. Decentralized systems, they argued, generally lift more boats than centralized ones. The worry that we had about the "digital divide" didn't really transpire. Look at cell phone use in Africa, for example, and how Africans have become world leaders at innovative uses of these devices.
The panelists also emphasized that some aspects of the inequality question are not so simple. If we look backward, for instance, the automobile was democratized, but no one here would say that we don't live in an unequal society. Technology, no matter how wonderful, will not address why inequality exists in the first place. Technology is not a panacea for solving society's ills.
The panel also addressed the risk question. One danger is that we will be reactive to events as they occur, for instance a bioengineered virus scare, and overregulate the domain so much that we eliminate the innovative space. It's far better to get ahead of the issue so that we don't run into this reactive dynamic.
The panel also tackled the do-it-yourself (DIY) movement in the biotech space. There is a great deal of innovation from small-scale tinkerers, and we should be concerned about the downsides from malevolent hackers. But biology is very complicated, and one of the panelists' messages was that it is exceedingly difficult to create lethal bio-weapons. On the other hand, the barriers that have existed, that get in the way to building nightmare biotech weapons, are falling.
The panel agreed that controlling the information that is behind the construction of such weapons is not an answer. Not only will the information leak out if we try to contain it, limiting legitimate work will discourage beneficial innovation. The best strategy is to invest in resiliency and preparedness strategies to anticipate events and respond quickly and effectively to them.
On the privacy question, the panel agreed that it is imperative to ensure cybersecurity (with respect to cloud storage) so that individual biological data is kept private.
Even more generally, however, the panelists leveled some criticism of science itself, and the scientific process as well. What we believe to be true now, scientifically speaking, is not what we will believe decades from now. Neither scientists nor the scientific process is fail-safe, and we should view both skeptically as we go ahead, as we should of all knowledge.